Anti-Mullerian hormone does not predict cumulative pregnancy rate in non-infertile women following four IUI cycles with donor sperm.

ABSTRACT:

Purpose

To evaluate the predictive value of serum AMH for clinical pregnancy in non-infertile population undergoing intrauterine insemination with donor sperm (ds-IUI).

Methods

This multicenter prospective study (ClinicalTrials.gov ID: NCT06263192) recruited all non-infertile women undergoing ds-IUI from June 2020 to December 2022 in three different fertility clinics in Spain and Chile. Indications for ds-IUI included severe oligoasthenoteratozoospermia, female partner, or single status. Clinical pregnancy rates were compared between women with AMH ≥ 1.1 and < 1.1 ng/mL. The main outcome measure was the cumulative clinical pregnancy rate after up to 4 ds-IUI cycles.

Results

A total of 458 ds-IUI cycles were performed among 245 patients, of whom 108 (44.08%) achieved c

SUBMITTER: Gayete-Lafuente S 

PROVIDER: S-EPMC11405616 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature